KELLY SISSON: Open Payments
NPI 1225604093 · LAWRENCEVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$978 in 38 payments from 17 companies in 2025. Trend: 2023 $239 · 2024 $421 · 2025 $978
Food & beverage: $978
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 9 | $189 |
| Boston Scientific Corporation | 2 | $153 |
| Medtronic, Inc. | 1 | $131 |
| ABIOMED | 2 | $85 |
| Alnylam Pharmaceuticals Inc. | 3 | $66 |
| Amgen Inc. | 4 | $59 |
| Novo Nordisk Inc | 3 | $50 |
| BridgeBio Pharma, Inc. | 2 | $45 |
| LANTHEUS MEDICAL IMAGING, INC. | 2 | $41 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $36 |
Products named: LEQVIO, MICRA, WATCHMAN Access System, AMVUTTRA, REPATHA, Wegovy, General - Therapies, Attruby.
Industry payments across GA — which companies pay providers there.
